Become an EMPEA Member Today

Capital Group Private Markets Acquires Stake in Intas Pharmaceuticals from ChrysCapital (Asia)

Posted on: 3 Apr 2017  |  Source(s): Livemint | Author(s): Reghu Balakrishnan

Pan-emerging markets private equity fund manager Capital Group Private Markets has acquired a 3 percent stake in India-based Intas Pharmaceuticals from India-focused private equity firm ChrysCapital for a reported US$107 million. ChrysCapital, which will retain a 3 percent stake in the company, originally invested in Intas in 2006 through ChrysCapital III and subsequently in 2012 through ChrysCapital IV.

< Previous Entry

Next Entry >